Literature DB >> 9311976

X-ray structure of antistasin at 1.9 A resolution and its modelled complex with blood coagulation factor Xa.

R Lapatto1, U Krengel, H A Schreuder, A Arkema, B de Boer, K H Kalk, W G Hol, P D Grootenhuis, J W Mulders, R Dijkema, H J Theunissen, B W Dijkstra.   

Abstract

The three-dimensional structure of antistasin, a potent inhibitor of blood coagulation factor Xa, from the Mexican leech Haementeria officinalis was determined at 1.9 A resolution by X-ray crystallography. The structure reveals a novel protein fold composed of two homologous domains, each resembling the structure of hirustasin, a related 55-residue protease inhibitor. However, hirustasin has a different overall shape than the individual antistasin domains, it contains four rather than two beta-strands, and does not inhibit factor Xa. The two antistasin domains can be subdivided into two similarly sized subdomains with different relative orientations. Consequently, the domain shapes are different, the N-terminal domain being wedge-shaped and the C-terminal domain flat. Docking studies suggest that differences in domain shape enable the N-terminal, but not C-terminal, domain of antistasin to bind and inhibit factor Xa, even though both have a very similar reactive site. Furthermore, a putative exosite binding region could be defined in the N-terminal domain of antistasin, comprising residues 15-17, which is likely to interact with a cluster of positively charged residues on the factor Xa surface (Arg222/Lys223/Lys224). This exosite binding region explains the specificity and inhibitory potency of antistasin towards factor Xa. In the C-terminal domain of antistasin, these exosite interactions are prevented due to the different overall shape of this domain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311976      PMCID: PMC1170148          DOI: 10.1093/emboj/16.17.5151

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  27 in total

1.  Correlation of binding affinities with non-bonded interaction energies of thrombin-inhibitor complexes.

Authors:  P D Grootenhuis; P J van Galen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1995-07-01

2.  Acceleration of recombinant tissue-type plasminogen activator-induced reperfusion and prevention of reocclusion by recombinant antistasin, a selective factor Xa inhibitor, in a canine model of femoral arterial thrombosis.

Authors:  M J Mellott; M A Holahan; J J Lynch; G P Vlasuk; C T Dunwiddie
Journal:  Circ Res       Date:  1992-06       Impact factor: 17.367

3.  Cloning and expression of cDNA encoding antistasin, a leech-derived protein having anti-coagulant and anti-metastatic properties.

Authors:  J H Han; S W Law; P M Keller; P J Kniskern; M Silberklang; J S Tung; T B Gasic; G J Gasic; P A Friedman; R W Ellis
Journal:  Gene       Date:  1989-01-30       Impact factor: 3.688

4.  Diffraction methods for biological macromolecules. Interactive computer graphics: FRODO.

Authors:  T A Jones
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

5.  Comparison of the in vivo anticoagulant properties of standard heparin and the highly selective factor Xa inhibitors antistasin and tick anticoagulant peptide (TAP) in a rabbit model of venous thrombosis.

Authors:  G P Vlasuk; D Ramjit; T Fujita; C T Dunwiddie; E M Nutt; D E Smith; R J Shebuski
Journal:  Thromb Haemost       Date:  1991-03-04       Impact factor: 5.249

6.  Isolation and characterization of antistasin. An inhibitor of metastasis and coagulation.

Authors:  G P Tuszynski; T B Gasic; G J Gasic
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

7.  Structure of human des(1-45) factor Xa at 2.2 A resolution.

Authors:  K Padmanabhan; K P Padmanabhan; A Tulinsky; C H Park; W Bode; R Huber; D T Blankenship; A D Cardin; W Kisiel
Journal:  J Mol Biol       Date:  1993-08-05       Impact factor: 5.469

8.  Ghilantens: anticoagulant-antimetastatic proteins from the South American leech, Haementeria ghilianii.

Authors:  R G Brankamp; D T Blankenship; P S Sunkara; A D Cardin
Journal:  J Lab Clin Med       Date:  1990-01

9.  Antistasin, a leech-derived inhibitor of factor Xa. Kinetic analysis of enzyme inhibition and identification of the reactive site.

Authors:  C Dunwiddie; N A Thornberry; H G Bull; M Sardana; P A Friedman; J W Jacobs; E Simpson
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

10.  The 2.5 A X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha-chymotrypsin.

Authors:  M G Grütter; G Fendrich; R Huber; W Bode
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  5 in total

1.  Recombinant decorsin: dynamics of the RGD recognition site.

Authors:  A M Krezel; J S Ulmer; G Wagner; R A Lazarus
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

2.  X-ray structure of T4 endonuclease VII: a DNA junction resolvase with a novel fold and unusual domain-swapped dimer architecture.

Authors:  H Raaijmakers; O Vix; I Törõ; S Golz; B Kemper; D Suck
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

3.  Lufaxin, a novel factor Xa inhibitor from the salivary gland of the sand fly Lutzomyia longipalpis blocks protease-activated receptor 2 activation and inhibits inflammation and thrombosis in vivo.

Authors:  Nicolas Collin; Teresa C F Assumpção; Daniella M Mizurini; Dana C Gilmore; Angélica Dutra-Oliveira; Michalis Kotsyfakis; Anderson Sá-Nunes; Clarissa Teixeira; José M C Ribeiro; Robson Q Monteiro; Jesus G Valenzuela; Ivo M B Francischetti
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-12       Impact factor: 8.311

4.  Transcriptional analysis of a unique set of genes involved in Schistosoma mansoni female reproductive biology.

Authors:  Alexis A Cogswell; Valerie P Kommer; David L Williams
Journal:  PLoS Negl Trop Dis       Date:  2012-11-15

5.  The Origin and Evolution of Antistasin-like Proteins in Leeches (Hirudinida, Clitellata).

Authors:  Rafael Eiji Iwama; Michael Tessler; Mark E Siddall; Sebastian Kvist
Journal:  Genome Biol Evol       Date:  2021-01-07       Impact factor: 3.416

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.